Avatar
Middle6waste

0 Following 0 Followers
1
Ovary [38], indicating a possibly different role of ALDH1 in ovarian cancer. Our present immunohistochemical study of 248 wellcharacterized patients showed high levels of ALDH1 expression in ovarian carcinoma cells, which were observed in 15.7 of the total cases, was associated with early-stage tumor, well-differentiated tumor and better survivals, although ALDH1 was not an independent risk fact
1
Ovary [38], indicating a possibly different role of ALDH1 in ovarian cancer. Our present immunohistochemical study of 248 wellcharacterized patients showed high levels of ALDH1 expression in ovarian carcinoma cells, which were observed in 15.7 of the total cases, was associated with early-stage tumor, well-differentiated tumor and better survivals, although ALDH1 was not an independent risk fact
1
The rise of CSC theory, some specific CSC markers were being discovered to identify putative CSCs, and ALDH1 is becoming to act as a CSC marker in the CSC studies of variable tumor types in vitro and in vivo. Epithelial-to-mesenchymal transition (EMT) is an important driver of tumor invasion and metastasis, which may be a feature of CSC. Compared to ALDH1(-) EMT cells, only ALDH1(+) EMT cells had
1
) 92 (69.2 ) 0.655 28 18 117 79 6 2 (7.1 ) 0 (.0 ) 6 (5.1 ) 5 (6.3 ) 8 (28.6 ) 10 (55.6 ) 27 (23.1 ) 14 (17.7 ) 18 (64.3 ) 8 (44.4 ) 84 (71.8 ) 60 (75.9 ) 0.161 163 18 19 11 11 5 21 6 (3.7 ) 3 (16.7 ) 0 (.0 ) 1 (9.1 ) 0 (.0 ) 1 (20.0 ) 36 (22.1 ) 6 (33.3 ) 7 (36.8 ) 1 (9.1 ) 4 (36.4 ) 1 (20.0 ) 121 (74.2 ) 9 (50.0 ) 12 (63.2 ) 9 (81.8 ) 7 (63.6 ) 3 (60.0 ) 0.077 16 4
1
) 92 (69.2 ) 0.655 28 18 117 79 6 2 (7.1 ) 0 (.0 ) 6 (5.1 ) 5 (6.3 ) 8 (28.6 ) 10 (55.6 ) 27 (23.1 ) 14 (17.7 ) 18 (64.3 ) 8 (44.4 ) 84 (71.8 ) 60 (75.9 ) 0.161 163 18 19 11 11 5 21 6 (3.7 ) 3 (16.7 ) 0 (.0 ) 1 (9.1 ) 0 (.0 ) 1 (20.0 ) 36 (22.1 ) 6 (33.3 ) 7 (36.8 ) 1 (9.1 ) 4 (36.4 ) 1 (20.0 ) 121 (74.2 ) 9 (50.0 ) 12 (63.2 ) 9 (81.8 ) 7 (63.6 ) 3 (60.0 ) 0.077 16 4
1
Ovary [38], indicating a possibly different role of ALDH1 in ovarian cancer. Our present immunohistochemical study of 248 wellcharacterized patients showed high levels of ALDH1 expression in ovarian carcinoma cells, which were observed in 15.7 of the total cases, was associated with early-stage tumor, well-differentiated tumor and better survivals, although ALDH1 was not an independent risk fact
1
Ovary [38], indicating a possibly different role of ALDH1 in ovarian cancer. Our present immunohistochemical study of 248 wellcharacterized patients showed high levels of ALDH1 expression in ovarian carcinoma cells, which were observed in 15.7 of the total cases, was associated with early-stage tumor, well-differentiated tumor and better survivals, although ALDH1 was not an independent risk fact
1
Ovary [38], indicating a possibly different role of ALDH1 in ovarian cancer. Our present immunohistochemical study of 248 wellcharacterized patients showed high levels of ALDH1 expression in ovarian carcinoma cells, which were observed in 15.7 of the total cases, was associated with early-stage tumor, well-differentiated tumor and better survivals, although ALDH1 was not an independent risk fact